Victory Capital Management
KRTX

Victory Capital Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Victory Capital Management’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4,338
Closed -$1.37M – 2605
2023
Q4 		$1.37M Buy
4,338
+778
+22% +$151K ﹤0.01% 1570
2023
Q3 		$602K Sell
3,560
-2,645
-43% -$497K ﹤0.01% 1904
2023
Q2 		$1.35M Buy
6,205
+1,204
+24% +$258K ﹤0.01% 1529
2023
Q1 		$908K Buy
5,001
+453
+10% +$86.6K ﹤0.01% 1750
2022
Q4 		$894K Buy
4,548
+1,663
+58% +$357K ﹤0.01% 1793
2022
Q3 		$649K Sell
2,885
-232,182
-99% -$47M ﹤0.01% 1933
2022
Q2 		$29.7M Sell
235,067
-123,683
-34% -$14.2M 0.03% 668
2022
Q1 		$45.5M Buy
358,750
+76,418
+27% +$8.6M 0.05% 568
2021
Q4 		$37M Buy
282,332
+279,938
+11,693% +$36.2M 0.03% 675
2021
Q3 		$293K Sell
2,394
-112
-4% -$12.9K ﹤0.01% 2392
2021
Q2 		$286K Sell
2,506
-2,946
-54% -$344K ﹤0.01% 2433
2021
Q1 		$655K Sell
5,452
-2,563
-32% -$290K ﹤0.01% 2078
2020
Q4 		$814K Buy
8,015
+2,840
+55% +$263K ﹤0.01% 1877
2020
Q3 		$400K Buy
+5,175
New +$441K ﹤0.01% 2041
2020
Q2 		– Sell
-4,056
Closed -$292K – 3431
2020
Q1 		$292K Buy
+4,056
New +$347K ﹤0.01% 2242
2019
Q4 		– Sell
-1,014
Closed -$17K – 3416
2019
Q3 		$17K Buy
+1,014
New +$19.7K ﹤0.01% 3106

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Victory Capital Management's KRTX Position: Q1 2024 in Review

Victory Capital Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 4,338 shares — an estimated $1.37M sold.

Victory Capital Management first reported a position in KRTX in Q3 2019 and held it in 16 quarters. The position peaked at $45.5M in Q1 2022. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Victory Capital Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Victory Capital Management sold 4,338 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $1.37M.
  • Victory Capital Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2019 and held it in 16 quarters.
  • Victory Capital Management's Karuna Therapeutics, Inc. Common Stock position peaked at $45.5M in Q1 2022.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Victory Capital Management's 13F filing for Q1 2024, filed 3 May 2024.